Skip to main content
Erschienen in: Neurocritical Care 1/2022

22.03.2022 | Original work

Prognostication of ICU Patients by Providers with and without Neurocritical Care Training

verfasst von: Anna Finley Caulfield, Michael Mlynash, Irina Eyngorn, Maarten G. Lansberg, Anousheh Afjei, Chitra Venkatasubramanian, Marion S. Buckwalter, Karen G. Hirsch

Erschienen in: Neurocritical Care | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Predictions of functional outcome in neurocritical care (NCC) patients impact care decisions. This study compared the predictive values (PVs) of good and poor functional outcome among health care providers with and without NCC training.

Methods

Consecutive patients who were intubated for  ≥ 72 h with primary neurological illness or neurological complications were prospectively enrolled and followed for 6-month functional outcome. Medical intensive care unit (MICU) attendings, NCC attendings, residents (RES), and nurses (RN) predicted 6-month functional outcome on the modified Rankin scale (mRS). The primary objective was to compare these four groups’ PVs of a good (mRS score 0–3) and a poor (mRS score 4–6) outcome prediction.

Results

Two hundred eighty-nine patients were enrolled. One hundred seventy-six had mRS scores predicted by a provider from each group and were included in the primary outcome analysis. At 6 months, 54 (31%) patients had good outcome and 122 (69%) had poor outcome. Compared with other providers, NCC attendings expected better outcomes (p < 0.001). Consequently, the PV of a poor outcome prediction by NCC attendings was higher (96% [95% confidence interval [CI] 89–99%]) than that by MICU attendings (88% [95% CI 80–93%]), RES (82% [95% CI 74–88%]), and RN (85% [95% CI 77–91%]) (p = 0.047, 0.002, and 0.012, respectively). When patients who had withdrawal of life-sustaining therapy (n = 67) were excluded, NCC attendings remained better at predicting poor outcome (NCC 90% [95% CI 75–97%] vs. MICU 73% [95% CI 59–84%], p = 0.064). The PV of a good outcome prediction was similar among groups (MICU 65% [95% CI 52–76%], NCC 63% [95% CI 51–73%], RES 71% [95% CI 55–84%], and RN 64% [95% CI 50–76%]).

Conclusions

Neurointensivists expected better outcomes than other providers and were better at predicting poor functional outcomes. The PV of a good outcome prediction was modest among all providers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Hemphill JC III, Bonovich DC, Besmertis L, et al. The ICH Score: A simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.CrossRef Hemphill JC III, Bonovich DC, Besmertis L, et al. The ICH Score: A simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.CrossRef
4.
Zurück zum Zitat Hemphill JC III, Farrant M, Neill TA. Prospective validation of the ICH score for 12-month functional outcome. Neurology. 2009;73:1088–94.CrossRef Hemphill JC III, Farrant M, Neill TA. Prospective validation of the ICH score for 12-month functional outcome. Neurology. 2009;73:1088–94.CrossRef
5.
Zurück zum Zitat Zahuranec DB, Lisabeth LD, Sánchez BN, et al. Intracerebral hemorrhage mortality is not changing despite declining incidence. Neurology. 2014;82:2180–6.CrossRef Zahuranec DB, Lisabeth LD, Sánchez BN, et al. Intracerebral hemorrhage mortality is not changing despite declining incidence. Neurology. 2014;82:2180–6.CrossRef
6.
Zurück zum Zitat Gadhia R, McCane D, Lee J, Ling KC, Jiang K, Chui D. The HOPES registry-Houston methodist hospital outcomes-based prospective endpoints in stroke. J Stroke Cerebrovasc Dis. 2018;27:2973–6.CrossRef Gadhia R, McCane D, Lee J, Ling KC, Jiang K, Chui D. The HOPES registry-Houston methodist hospital outcomes-based prospective endpoints in stroke. J Stroke Cerebrovasc Dis. 2018;27:2973–6.CrossRef
7.
Zurück zum Zitat Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6–16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–18.CrossRef Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6–16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–18.CrossRef
8.
Zurück zum Zitat Sculier C, Gainza-Lein M, Fernandez IS, Loddenkemper T. Long-term outcomes of status epilepticus: a critical assessment. Epilepsia. 2018;59(Suppl 2):155–69.CrossRef Sculier C, Gainza-Lein M, Fernandez IS, Loddenkemper T. Long-term outcomes of status epilepticus: a critical assessment. Epilepsia. 2018;59(Suppl 2):155–69.CrossRef
9.
Zurück zum Zitat Cook D, Rocker G, Marshall J, et al. Withdraw of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med. 2003;349:1123–32.CrossRef Cook D, Rocker G, Marshall J, et al. Withdraw of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med. 2003;349:1123–32.CrossRef
10.
Zurück zum Zitat Diringer M, Edwards D, Aiyagari V, Hollingsworth H. Factors associated with withdrawal of mechanical ventilation in the neurology/neurosurgery intensive care unit. Crit Care Med. 2001;29:1792–7.CrossRef Diringer M, Edwards D, Aiyagari V, Hollingsworth H. Factors associated with withdrawal of mechanical ventilation in the neurology/neurosurgery intensive care unit. Crit Care Med. 2001;29:1792–7.CrossRef
11.
Zurück zum Zitat Smith AK, White DB, Arnold RM. Uncertainty-the other side of prognosis. N Engl J Med. 2013;368(26):2448–50.CrossRef Smith AK, White DB, Arnold RM. Uncertainty-the other side of prognosis. N Engl J Med. 2013;368(26):2448–50.CrossRef
12.
Zurück zum Zitat Finley Caulfield A, Gabler L, Lansberg MG, et al. Outcome prediction in mechanically ventilated neurologic patients by junior neurointensivists. Neurology. 2010;74:1096–101.CrossRef Finley Caulfield A, Gabler L, Lansberg MG, et al. Outcome prediction in mechanically ventilated neurologic patients by junior neurointensivists. Neurology. 2010;74:1096–101.CrossRef
13.
Zurück zum Zitat Hwang DY, Dell CA, Sparks MJ, et al. Clinician judgement versus formal scales for predicting intracerebral hemorrhage outcomes. Neurology. 2016;86:126–33.CrossRef Hwang DY, Dell CA, Sparks MJ, et al. Clinician judgement versus formal scales for predicting intracerebral hemorrhage outcomes. Neurology. 2016;86:126–33.CrossRef
14.
Zurück zum Zitat Chu SY, Hwang DY. Predicting outcome for intracerebral hemorrhage patients: current tools and their limitations. Semin Neurol. 2016;36:254–60.CrossRef Chu SY, Hwang DY. Predicting outcome for intracerebral hemorrhage patients: current tools and their limitations. Semin Neurol. 2016;36:254–60.CrossRef
15.
Zurück zum Zitat van Swieten JC, Koudstaal PJ, Visser MC, Shouten HJ, van Gijn J. Inter-observer agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.CrossRef van Swieten JC, Koudstaal PJ, Visser MC, Shouten HJ, van Gijn J. Inter-observer agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.CrossRef
16.
Zurück zum Zitat Lopez-Cancio E, Salvat M, Cerda N, et al. Phone and video-based modalities of central blinded adjudication of modified rankin scores in an endovascular stroke trial. Stroke. 2015;46:3405–10.CrossRef Lopez-Cancio E, Salvat M, Cerda N, et al. Phone and video-based modalities of central blinded adjudication of modified rankin scores in an endovascular stroke trial. Stroke. 2015;46:3405–10.CrossRef
17.
Zurück zum Zitat Wilson JTL, Pettigrew LEL, Teasdale GM. Structural interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their use. J Neurotrauma. 1998;15:573–85.CrossRef Wilson JTL, Pettigrew LEL, Teasdale GM. Structural interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their use. J Neurotrauma. 1998;15:573–85.CrossRef
18.
Zurück zum Zitat Pettigrew LEL, Wilson JTL, Teasdale GM. Reliability of ratings on the Glasgow outcome scales from in-person and telephone structured interviews. J Head Trauma Rehabil. 2003;18:252–8.CrossRef Pettigrew LEL, Wilson JTL, Teasdale GM. Reliability of ratings on the Glasgow outcome scales from in-person and telephone structured interviews. J Head Trauma Rehabil. 2003;18:252–8.CrossRef
19.
Zurück zum Zitat Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–5.PubMed Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–5.PubMed
20.
Zurück zum Zitat Korner-Bitensky N, Wood-Dauphinee S. Barthel index information elicited over the telephone. Is it reliable? Am J Phys Med Rehabil. 1995;74:9–18.CrossRef Korner-Bitensky N, Wood-Dauphinee S. Barthel index information elicited over the telephone. Is it reliable? Am J Phys Med Rehabil. 1995;74:9–18.CrossRef
21.
Zurück zum Zitat Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. New Engl J Med. 2005;352:777–85.CrossRef Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. New Engl J Med. 2005;352:777–85.CrossRef
22.
Zurück zum Zitat Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomized controlled trials. Lancet Neurol. 2007;6:215–22.CrossRef Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomized controlled trials. Lancet Neurol. 2007;6:215–22.CrossRef
23.
Zurück zum Zitat Vahedi K, Vicant E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38:2506–17.CrossRef Vahedi K, Vicant E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38:2506–17.CrossRef
24.
Zurück zum Zitat Juttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518–25.CrossRef Juttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518–25.CrossRef
25.
Zurück zum Zitat Hofmeijer J, Kapelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicenter, open, randomized trial. Lancet Neurol. 2009;8:326–33.CrossRef Hofmeijer J, Kapelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicenter, open, randomized trial. Lancet Neurol. 2009;8:326–33.CrossRef
26.
Zurück zum Zitat Berkhemer OA, Fransen PSS, Beurmer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.CrossRef Berkhemer OA, Fransen PSS, Beurmer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.CrossRef
27.
Zurück zum Zitat van den Berg LA, Dijkgraaf MGW, Berkhemer OA, et al. Two-year outcome after endovascular treatment for acute ischemic stroke. N Engl J Med. 2017;376:1341–9.CrossRef van den Berg LA, Dijkgraaf MGW, Berkhemer OA, et al. Two-year outcome after endovascular treatment for acute ischemic stroke. N Engl J Med. 2017;376:1341–9.CrossRef
28.
Zurück zum Zitat Qureshi AI, Palesch YY, Barsan WG, et al. for the ATACH-2 Trial investigators and the neurological emergency treatment trials network. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033–43.CrossRef Qureshi AI, Palesch YY, Barsan WG, et al. for the ATACH-2 Trial investigators and the neurological emergency treatment trials network. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033–43.CrossRef
29.
Zurück zum Zitat Hanley DF, Lane K, McBee N, et al. for the CLEAR III Investigators. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomized, multicenter, multiregional, placebo-controlled CLEAR II trial. Lancet 2017; 389:603–611. Hanley DF, Lane K, McBee N, et al. for the CLEAR III Investigators. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomized, multicenter, multiregional, placebo-controlled CLEAR II trial. Lancet 2017; 389:603–611.
30.
Zurück zum Zitat Hanley DF, Thompson RE, Rosenblum M, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomized, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393:1021–32.CrossRef Hanley DF, Thompson RE, Rosenblum M, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomized, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393:1021–32.CrossRef
31.
Zurück zum Zitat Witsch J, Frey HP, Patel S, et al. Prognostication of long-term outcomes after subarachnoid hemorrhage: the FRESH score. Ann Neurol. 2016;80:46–58.CrossRef Witsch J, Frey HP, Patel S, et al. Prognostication of long-term outcomes after subarachnoid hemorrhage: the FRESH score. Ann Neurol. 2016;80:46–58.CrossRef
32.
Zurück zum Zitat Creutzfeldt CJ, Halloway RG. Treatment decisions after severe stroke – uncertainty and biases. Stroke. 2012;43:3405–8.CrossRef Creutzfeldt CJ, Halloway RG. Treatment decisions after severe stroke – uncertainty and biases. Stroke. 2012;43:3405–8.CrossRef
33.
Zurück zum Zitat Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all odds. Soc Sci Med. 1999;48:977–88.CrossRef Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all odds. Soc Sci Med. 1999;48:977–88.CrossRef
34.
Zurück zum Zitat Saposnik G, Cote R, Mamdani M, et al. JURaSSiC Accuracy of clinician versus risk score prediction of ischemic stroke outcomes. Neurology. 2013;81:448–55.CrossRef Saposnik G, Cote R, Mamdani M, et al. JURaSSiC Accuracy of clinician versus risk score prediction of ischemic stroke outcomes. Neurology. 2013;81:448–55.CrossRef
35.
Zurück zum Zitat Becker KJ, Baxter AB, Cohen WA, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56(6):766-772.25.CrossRef Becker KJ, Baxter AB, Cohen WA, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56(6):766-772.25.CrossRef
36.
Zurück zum Zitat Hemphill JC III, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004;35(5):1130–4.CrossRef Hemphill JC III, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004;35(5):1130–4.CrossRef
37.
Zurück zum Zitat Zahuranec DB, Brown DL, Lisabeth LD, et al. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology. 2007;68(20):1651–7.CrossRef Zahuranec DB, Brown DL, Lisabeth LD, et al. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology. 2007;68(20):1651–7.CrossRef
38.
Zurück zum Zitat Silvennoinen K, Meretoja A, Strbian D, Putaala J, Kaste M, Tatlisumak T. Do-not-resuscitate (DNR) orders in patients with intracerebral hemorrhage. Int J Stroke. 2014;9(1):53–8.CrossRef Silvennoinen K, Meretoja A, Strbian D, Putaala J, Kaste M, Tatlisumak T. Do-not-resuscitate (DNR) orders in patients with intracerebral hemorrhage. Int J Stroke. 2014;9(1):53–8.CrossRef
39.
Zurück zum Zitat Creutzfeldt CJ, Becker KJ, Weinstein JR, et al. Do-not-attempt resuscitation orders and prognostic models for intraparenchymal hemorrhage. Crit Care Med. 2011;39(1):158–62.CrossRef Creutzfeldt CJ, Becker KJ, Weinstein JR, et al. Do-not-attempt resuscitation orders and prognostic models for intraparenchymal hemorrhage. Crit Care Med. 2011;39(1):158–62.CrossRef
40.
Zurück zum Zitat Morgenstern LB, Zahuranec DB, Sánchez BN, et al. Full medical support for intracerebral hemorrhage. Neurology. 2015;84(17):1739–44.CrossRef Morgenstern LB, Zahuranec DB, Sánchez BN, et al. Full medical support for intracerebral hemorrhage. Neurology. 2015;84(17):1739–44.CrossRef
41.
Zurück zum Zitat Hemphill JC III, Greenberg SM, Anderson CS, et al. AHA/ASA Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2015;46:2032–60.CrossRef Hemphill JC III, Greenberg SM, Anderson CS, et al. AHA/ASA Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2015;46:2032–60.CrossRef
42.
Zurück zum Zitat Kiphuth IC, Köhrmann M, Lichy C, Schwab S, Huttner HB. Hemicraniectomy for malignant middle cerebral artery infarction: retrospective consent to decompressive surgery depends on functional long-term outcome. Neurocrit Care. 2010;13:380–4.CrossRef Kiphuth IC, Köhrmann M, Lichy C, Schwab S, Huttner HB. Hemicraniectomy for malignant middle cerebral artery infarction: retrospective consent to decompressive surgery depends on functional long-term outcome. Neurocrit Care. 2010;13:380–4.CrossRef
43.
Zurück zum Zitat Zier LS, Burack JH, Micco G, et al. Doubt and belief in physicians’ ability to prognosticate during critical illness: the perspective of surrogate decision makers. Crit Care Med. 2008;36:2341–7.CrossRef Zier LS, Burack JH, Micco G, et al. Doubt and belief in physicians’ ability to prognosticate during critical illness: the perspective of surrogate decision makers. Crit Care Med. 2008;36:2341–7.CrossRef
Metadaten
Titel
Prognostication of ICU Patients by Providers with and without Neurocritical Care Training
verfasst von
Anna Finley Caulfield
Michael Mlynash
Irina Eyngorn
Maarten G. Lansberg
Anousheh Afjei
Chitra Venkatasubramanian
Marion S. Buckwalter
Karen G. Hirsch
Publikationsdatum
22.03.2022
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 1/2022
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-022-01467-6

Weitere Artikel der Ausgabe 1/2022

Neurocritical Care 1/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.